https://www.selleckchem.com/pr....oducts/gsk-j4-hcl.ht
Patients who opted for cochlear implantation had a poorer quality of life (P=.03). The improvement of quality of life indices after each trial was significantly associated with the final treatment choice (P=.008 for generic indices, P=.002 for auditory-specific indices). The follow-up showed that this improvement had been overestimated in the CROS group, with a long-term retention rate of 52.5%. More than one third of SSD/AHL subjects are unsatisfied after CROS and BCD trials. Repeated quality of life assessments help counselling the
Me gusta
Comentario
Compartir
